Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing
Journal: Journal of Antimicrobial Chemotherapy
Year: 2014

Pre-existing MVs more than double the risk of virological failure to first-line NNRTI-based ART.